Clinical Trial: A Study to Evaluate the Safety and Pharmacokinetics of AD-228A Compared to Coadministration of AD-2281 and AD-2282

U.S., March 6 -- ClinicalTrials.gov registry received information related to the study (NCT06858865) titled 'A Study to Evaluate the Safety and Pharmacokinetics of AD-228A Compared to Coadministration of AD-2281 and AD-2282' on Feb. 28.

Brief Summary: Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of AD-228A in healthy subjects.

Study Start Date: March 25

Study Type: INTERVENTIONAL

Condition: Primary Hypercholesterolaemia

Intervention: DRUG: AD-228A

AD-228A Oral Tablet

DRUG: AD-2281 and AD-2282

AD-2281 Oral Tablet + AD-2282 Oral Tablet

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Addpharma Inc.

Published by HT Digital Content Services with permission from Health Daily Digest....